259 related articles for article (PubMed ID: 17502120)
1. Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors.
Dubois L; Douma K; Supuran CT; Chiu RK; van Zandvoort MA; Pastoreková S; Scozzafava A; Wouters BG; Lambin P
Radiother Oncol; 2007 Jun; 83(3):367-73. PubMed ID: 17502120
[TBL] [Abstract][Full Text] [Related]
2. Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model.
Dubois L; Lieuwes NG; Maresca A; Thiry A; Supuran CT; Scozzafava A; Wouters BG; Lambin P
Radiother Oncol; 2009 Sep; 92(3):423-8. PubMed ID: 19616332
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT
Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.
Svastová E; Hulíková A; Rafajová M; Zat'ovicová M; Gibadulinová A; Casini A; Cecchi A; Scozzafava A; Supuran CT; Pastorek J; Pastoreková S
FEBS Lett; 2004 Nov; 577(3):439-45. PubMed ID: 15556624
[TBL] [Abstract][Full Text] [Related]
5. Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells.
Rafajová M; Zatovicová M; Kettmann R; Pastorek J; Pastoreková S
Int J Oncol; 2004 Apr; 24(4):995-1004. PubMed ID: 15010840
[TBL] [Abstract][Full Text] [Related]
6. Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells.
Vordermark D; Kaffer A; Riedl S; Katzer A; Flentje M
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1197-207. PubMed ID: 15752902
[TBL] [Abstract][Full Text] [Related]
7. Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro.
Said HM; Polat B; Staab A; Hagemann C; Stein S; Flentje M; Theobald M; Katzer A; Vordermark D
Oncol Rep; 2008 Aug; 20(2):413-9. PubMed ID: 18636206
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
Cecchi A; Hulikova A; Pastorek J; Pastoreková S; Scozzafava A; Winum JY; Montero JL; Supuran CT
J Med Chem; 2005 Jul; 48(15):4834-41. PubMed ID: 16033263
[TBL] [Abstract][Full Text] [Related]
9. Expression Dynamics of CA IX Epitope in Cancer Cells under Intermittent Hypoxia Correlates with Extracellular pH Drop and Cell Killing by Ureido-Sulfonamide CA IX Inhibitors.
Sufian MA; Zamanova S; Shabana AM; Kemp B; Mondal UK; Supuran CT; Ilies MA
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902027
[TBL] [Abstract][Full Text] [Related]
10. Src induces expression of carbonic anhydrase IX via hypoxia-inducible factor 1.
Takacova M; Holotnakova T; Barathova M; Pastorekova S; Kopacek J; Pastorek J
Oncol Rep; 2010 Mar; 23(3):869-74. PubMed ID: 20127031
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis.
Yu SJ; Yoon JH; Lee JH; Myung SJ; Jang ES; Kwak MS; Cho EJ; Jang JJ; Kim YJ; Lee HS
Acta Pharmacol Sin; 2011 Jul; 32(7):912-20. PubMed ID: 21666701
[TBL] [Abstract][Full Text] [Related]
12. Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines.
Said HM; Staab A; Hagemann C; Vince GH; Katzer A; Flentje M; Vordermark D
J Neurooncol; 2007 Jan; 81(1):27-38. PubMed ID: 16944313
[TBL] [Abstract][Full Text] [Related]
13. Binding of carbonic anhydrase IX to 45S rDNA genes is prevented by exportin-1 in hypoxic cells.
Sasso E; Vitale M; Monteleone F; Boffo FL; Santoriello M; Sarnataro D; Garbi C; Sabatella M; Crifò B; Paolella LA; Minopoli G; Winum JY; Zambrano N
Biomed Res Int; 2015; 2015():674920. PubMed ID: 25793203
[TBL] [Abstract][Full Text] [Related]
14. High cell density-mediated pericellular hypoxia is a crucial factor inducing expression of the intrinsic hypoxia marker CA IX in vitro in HeLa cells.
Chrastina A
Neoplasma; 2003; 50(4):251-6. PubMed ID: 12937836
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment.
Perut F; Carta F; Bonuccelli G; Grisendi G; Di Pompo G; Avnet S; Sbrana FV; Hosogi S; Dominici M; Kusuzaki K; Supuran CT; Baldini N
Expert Opin Ther Targets; 2015; 19(12):1593-605. PubMed ID: 26357839
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325
[TBL] [Abstract][Full Text] [Related]
18. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
Thiry A; Dogné JM; Masereel B; Supuran CT
Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
[TBL] [Abstract][Full Text] [Related]
19. Role of aryl hydrocarbon receptor in modulation of the expression of the hypoxia marker carbonic anhydrase IX.
Takacova M; Holotnakova T; Vondracek J; Machala M; Pencikova K; Gradin K; Poellinger L; Pastorek J; Pastorekova S; Kopacek J
Biochem J; 2009 Apr; 419(2):419-25. PubMed ID: 19154183
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ
J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
